Does cholestyramine impair the bioavailability of prednisolone?
Audétat, V.; Paumgartner, G.; Bircher, J.
Schweizerische Medizinische Wochenschrift 107(15): 527-528
1977
ISSN/ISBN: 0036-7672 PMID: 854722 Document Number: 123609
Measurements of plasma prednisolone concentrations in two patients who received orally 37.5 and 75 mg of the drug respectively showed no differences when 8 g of cholestyramine was given with the corticosteroid. Thus, no influence of cholestyramine on the bioavailability of orally administered prednisolone could be demonstrated.
Document emailed within 1 workday
Related Documents
Tse, F.L.; Welling, P.G. 1979: Relative bioavailability of prednisone and prednisolone in man Journal of Pharmacy and Pharmacology 31(7): 492-493Shahidullah, M.; Haque, A.; Islam, M.R.; Rizvi, A.N.; Sultana, N.; Mia, B.A.; Hussain, M.A. 2011: Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy Mymensingh Medical Journal: Mmj 20(4): 605-613
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Firsov, A.A.; Piotrovskii, V.K. 1986: Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability Die Pharmazie 41(7): 457-465
Reissi, D.; Bardideh, A.; Samadzadeh, B.; Razi, A. 1995: Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation Transplantation Proceedings 27(5): 2685-2686
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Drobnjak, P.; Puharić, I. 1976: Does parotitis impair the fertilizing capacity of man? Lijecnicki Vjesnik 98(6): 329
Hecht, Y. 1978: Cholestyramine in hepatology Medecine and Chirurgie Digestives 7(8): 705-708
Gregus, Z.; Fekete, T.; Halászi, E.; Klaassen, C.D. 1996: Does hepatic ATP depletion impair glycine conjugation in vivo? Drug Metabolism and Disposition: the Biological Fate of Chemicals 24(12): 1347-1354
1979: Noisy work situations may impair vocal cords JAMA 241(20): 2133
Tashev, T.; Brailski, K.; Braikova, N.; Mendizova, A.; Adzharov, D. 1974: Treatment of cholestasis with cholestyramine Vutreshni Bolesti 13(1): 60-65
Thompson, W.G. 1971: Making cholestyramine palatable Canadian Medical Association Journal 104(11): 986
Poley, J.R. 1978: Cholestyramine and intestinal obstruction Pediatrics 61(2): 332
Perraudin, L.; Bernard, J.P.; Vial, T.; Descotes, J. 1989: Biostin (RU-41740) does not impair antipyrine metabolism in healthy volunteers Methods and Findings in Experimental and Clinical Pharmacology 11(9): 533
Krasner, D. 1995: Minimizing factors that impair wound healing: a nursing approach Ostomy/Wound Management 41(1): 22-26; 28 30; Quiz: 31-32
Randon, J.; Chignard, M.; Lecompte, T.; Dray, F.; Vargaftig, B.B. 1983: Methylation inhibitors impair collagen-induced activation of human platelets Thrombosis and Haemostasis 50(3): 756
Van Wyk, V.; Marais, A.; Diedericks, J.; van der Walt, E.; Dumas, L.; Badenhorst, P.N.; Alexander, K.C.; Kotzé, H.F. 1998: Plasma volume expansion with Haemaccel does not impair haemostasis during reduction mammaplasty South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 36(1): 22-25; Discussion: 25-26